Precision light therapy reshapes brain networks to alleviate Alzheimer’s cognitive deficits

Alzheimer's disease (AD) remains one of modern medicine's most daunting challenges, with conventional drug treatments offering limited efficacy. While transcranial near-infrared stimulation (tNIRS) has emerged as a promising non-invasive alternative, conventional whole-brain irradiation lacks anatomical precision, leading to inconsistent clinical outcomes.

In a breakthrough study published in BME Frontiers, a collaborative research team from Hebei Medical University and Capital Medical University has provided the first clinical evidence that targeted 810-nm tNIRS—aimed precisely at the bilateral angular gyrus (AG)—can markedly improve cognitive functions in AD patients.

The angular gyrus was selected as the target because it is a core hub of the Default Mode Network (DMN), a brain network that is highly vulnerable in AD and deeply involved in memory retrieval and multi-sensory integration. To rigorously test the intervention, the team conducted a randomized, sham-controlled, blinded clinical trial involving 36 patients with biomarker-confirmed mild AD. Participants received 20 minutes of daily tNIRS per hemisphere for 15 consecutive days.

The clinical results were highly encouraging. Patients receiving the active treatment showed comprehensive and significant improvements in global cognition, episodic memory, language, attention, and executive functions, alongside a marked reduction in neuropsychiatric symptoms. Crucially, the benefits were clinically meaningful, with average cognitive scale improvements exceeding the minimal clinically important difference thresholds.

To decode the underlying neural mechanisms, researchers utilized a combination of resting-state functional MRI (fMRI) and transcranial magnetic stimulation-electroencephalography (TMS-EEG). The data revealed that targeted tNIRS enhanced functional connectivity within the DMN and promoted functional synergy among higher-order cognitive networks. TMS-EEG further demonstrated enhanced dynamic information flow, specifically boosting neural activity in the prefrontal and temporo-occipital regions.

Optical Monte Carlo simulations based on a high-precision 3D human head model validated the physical foundation of the therapy. The 810-nm wavelength exhibited optimal biological characteristics—"low absorption and high scattering"—allowing a sufficient dose of photons to safely penetrate the scalp and skull to directly stimulate the deep brain targets.

"This study breaks away from the traditional multi-target intervention paradigm," the authors stated. "By using precise, single-target stimulation of the angular gyrus, we can elicit coordinated responses across multiple brain regions, offering a highly promising, mechanistic clinical neuromodulation strategy for Alzheimer's disease."

While future studies with larger cohorts and longer treatment protocols are needed to explore long-term maintenance schedules, this research establishes a novel paradigm for precise neurorehabilitation, proving that light can effectively awaken and reshape the human brain's cognitive networks.